BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 39 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,921 | -89.6% | 209,500 | +6.8% | 0.00% | – |
| Q2 2023 | $404,082 | -39.1% | 196,156 | -2.5% | 0.00% | – |
| Q1 2023 | $663,854 | +127.2% | 201,168 | +12.9% | 0.00% | – |
| Q4 2022 | $292,189 | -58.2% | 178,164 | +12.6% | 0.00% | – |
| Q3 2022 | $699,000 | +82.0% | 158,207 | +13.5% | 0.00% | – |
| Q2 2022 | $384,000 | -4.0% | 139,385 | +17.0% | 0.00% | – |
| Q1 2022 | $400,000 | -50.7% | 119,119 | -41.3% | 0.00% | – |
| Q4 2021 | $812,000 | +11.7% | 203,000 | -7.8% | 0.00% | – |
| Q3 2021 | $727,000 | -36.5% | 220,280 | -26.8% | 0.00% | – |
| Q2 2021 | $1,144,000 | -10.6% | 300,867 | -10.0% | 0.00% | – |
| Q1 2021 | $1,280,000 | -5.6% | 334,354 | +11.6% | 0.00% | – |
| Q4 2020 | $1,356,000 | -75.3% | 299,600 | -7.8% | 0.00% | -100.0% |
| Q3 2020 | $5,499,000 | +117.9% | 325,000 | +44.4% | 0.00% | 0.0% |
| Q2 2020 | $2,524,000 | +295.6% | 225,100 | +63.6% | 0.00% | – |
| Q1 2020 | $638,000 | +188.7% | 137,600 | +165.9% | 0.00% | – |
| Q4 2019 | $221,000 | +40.8% | 51,740 | +29.6% | 0.00% | – |
| Q2 2019 | $157,000 | +1.3% | 39,914 | +11.8% | 0.00% | – |
| Q1 2019 | $155,000 | +297.4% | 35,711 | +228.6% | 0.00% | – |
| Q4 2018 | $39,000 | -62.5% | 10,867 | -60.3% | 0.00% | – |
| Q3 2018 | $104,000 | +8.3% | 27,400 | +11.8% | 0.00% | – |
| Q2 2018 | $96,000 | +62.7% | 24,500 | +63.0% | 0.00% | – |
| Q4 2017 | $59,000 | -43.8% | 15,034 | -41.3% | 0.00% | – |
| Q3 2017 | $105,000 | -21.6% | 25,598 | -20.3% | 0.00% | – |
| Q2 2017 | $134,000 | +81.1% | 32,100 | +84.8% | 0.00% | – |
| Q1 2017 | $74,000 | +131.2% | 17,372 | +45.4% | 0.00% | – |
| Q1 2016 | $32,000 | – | 11,948 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 242,850 | $923,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 241,500 | $918,000 | 0.13% |
| Weaver Consulting Group | 48,881 | $186,000 | 0.10% |
| Tibra Equities Europe Ltd | 87,000 | $331,000 | 0.10% |
| Ikarian Capital, LLC | 293,200 | $1,115,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 60,238 | $229,000 | 0.03% |
| Ergoteles LLC | 124,329 | $472,000 | 0.01% |
| CFO4Life Group, LLC | 12,003 | $46,000 | 0.01% |
| HighPoint Advisor Group LLC | 17,033 | $65,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 32,836 | $125,000 | 0.00% |